Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathogenesis of postmenopausal osteoporosis.

× No keyword cloud information.

100 in total

1. Expression of estrogen receptor beta in rat bone.

Authors: Y Onoe; C Miyaura; H Ohta; S Nozawa; T Suda
Journal: Endocrinology Date: 1997-10 Impact factor: 4.736

2. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes.

Authors: H W Deng; J Li; J L Li; M Johnson; G Gong; K M Davis; R R Recker
Journal: Hum Genet Date: 1998-11 Impact factor: 4.132

Review 3. Cytokines in the pathogenesis of osteoporosis.

Authors: E Romas; T J Martin
Journal: Osteoporos Int Date: 1997 Impact factor: 4.507

4. Neonatal changes of osteoclasts in osteopetrosis (op/op) mice defective in production of functional macrophage colony-stimulating factor (M-CSF) protein and effects of M-CSF on osteoclast development and differentiation.

Authors: S Umeda; K Takahashi; M Naito; L D Shultz; K Takagi
Journal: J Submicrosc Cytol Pathol Date: 1996-01

5. The short-term effects of conjugated estrogen on bone turnover in older women.

Authors: K M Prestwood; C C Pilbeam; J A Burleson; F N Woodiel; P D Delmas; L J Deftos; L G Raisz
Journal: J Clin Endocrinol Metab Date: 1994-08 Impact factor: 5.958

Review 6. Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: the role of glutamate as a paracrine signaling agent in the skeleton.

Authors: T M Skerry
Journal: J Bone Miner Metab Date: 1999 Impact factor: 2.626

7. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

Authors: S K Lee; J A Lorenzo
Journal: Endocrinology Date: 1999-08 Impact factor: 4.736

8. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.

Authors: T Murakami; M Yamamoto; K Ono; M Nishikawa; N Nagata; K Motoyoshi; T Akatsu
Journal: Biochem Biophys Res Commun Date: 1998-11-27 Impact factor: 3.575

Review 3. The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis.

Authors: Silvia Migliaccio; Marina Brama; Giovanni Spera
Journal: Clin Interv Aging Date: 2007 Impact factor: 4.458

3 in total

Pathogenesis of postmenopausal osteoporosis.

1. Expression of estrogen receptor beta in rat bone.

2. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes.

Review 3. Cytokines in the pathogenesis of osteoporosis.

4. Neonatal changes of osteoclasts in osteopetrosis (op/op) mice defective in production of functional macrophage colony-stimulating factor (M-CSF) protein and effects of M-CSF on osteoclast development and differentiation.

5. The short-term effects of conjugated estrogen on bone turnover in older women.

Review 6. Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: the role of glutamate as a paracrine signaling agent in the skeleton.

7. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

8. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.

9. Local estradiol metabolism in osteoblast- and osteoclast-like cells.

Review 10. The effects of progressive resistance training on bone density: a review.

1. Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.

Review 2. Immunoporosis: Role of immune system in the pathophysiology of different types of osteoporosis.

Review 3. The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis.